SCHEMBL7305610

SCHEMBL7305610

CC1(C)O[C@H]([C@H](O)Cc2ccc3ccccc3c2)[C@@H]([C@H](O)Cc2ccc3ccccc3c2)O1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
CYP1A2 P05177 1/20 0.42
CYP2A6 P11509 1/20 0.42
ADRB2 P07550 2/20 0.40
SIGMAR1 Q99720 1/20 0.38
MMP9 P14780 1/20 0.37
MMP8 P22894 1/20 0.37
UGT2B7 P16662 1/20 0.37
TACR1 P25103 2/20 0.36
NR3C1 P04150 1/20 0.36
PGR P06401 1/20 0.36
NR3C2 P08235 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7277789 0.81 TRPA1 (0.41) CYP1A2CYP2A6SIGMAR1SLC6A2SLC6A4
SCHEMBL9708802 0.81 TRPA1 (0.41) CYP1A2CYP2A6SIGMAR1SLC6A2SLC6A4
SCHEMBL7300749 0.81 TRPA1 (0.41) CYP1A2CYP2A6SIGMAR1SLC6A2SLC6A4
SCHEMBL8465868 0.79 HTR2A (0.67) HTR2AHTR2CHTR2BCYP1A2CYP2A6
SCHEMBL7306558 0.77 CYP3A4 (0.45) UGT2B7SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7306681 0.76 HTR2A (0.41) HTR2AHTR2CHTR2BCYP1A2CYP2A6
SCHEMBL9176689 0.71 HTR2A (0.53) HTR2AHTR2CHTR2BCYP1A2CYP2A6
SCHEMBL6843917 0.69 HTR2A (0.52) HTR2AHTR2CHTR2BCYP1A2CYP2A6
SCHEMBL2482281 0.69 HTR2A (0.58) HTR2AHTR2CHTR2BCYP1A2CYP2A6
SCHEMBL5306693 0.69 HTR2A (0.56) HTR2AHTR2CHTR2BCYP1A2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0575097-A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS ELI LILLY AND COMPANY (US) 1993-12-22 EP disclosed